Maximize Your Impact at mRNA-Based Therapeutics Summit 2025
The mRNA-Based Therapeutics Summit 2025, taking place July 21 at The Westin Boston Seaport District, represents a high-value opportunity for commercial teams to connect with biopharmaceutical decision-makers driving the future of mRNA drug development. As the mRNA space evolves beyond vaccines into oncology, rare diseases, and protein replacement therapies, this summit gathers experts spearheading pipeline expansion, regulatory strategy, and platform optimization.
Attendees include R&D executives, biotech founders, clinical operations leads, and translational science professionals from emerging biotechs and large pharmaceutical companies. The strategic nature of the summit makes it a focal point for conversations around funding rounds, preclinical platforms, vendor selection, and long-term partnerships in the drug development lifecycle.
Engaging early with this audience can differentiate your company and position your team for influence across drug discovery, clinical development, and commercialization decisions. The enriched attendee list from Vendelux provides clarity on who’s expected, their project focus, and how to align your message with their scientific and business priorities.
How Sales, Marketing and Revops Teams Can Use This Attendee List
Biotech and life sciences commercial teams can leverage the enriched attendee data to fine-tune their outreach and relationship-building ahead of the mRNA-Based Therapeutics Summit 2025. Segment the attendee list based on company type, from early-stage biotech to global pharma, and by titles such as Chief Scientific Officer, VP of R&D, or Head of Business Development.
Use the conference attendees list to connect with teams running vendor evaluations for assay development, manufacturing tech, or data analytics. Coordinate early outbound to key decision-makers with verified budget authority. Tie your outreach to their trial timelines, therapeutic areas, or new pipeline buildouts.
Schedule meetings in advance using attendee data to target those with high technical understanding and relevant purchasing power. After the event, follow up with insights linked to their area of work—be it mRNA design, LNP formulation, or production scale-up—so post-event contacts lead to partnership conversations, not just vendor lists.
Timing Is Everything
The mRNA-Based Therapeutics Summit 2025 takes place July 21, 2025. Given the scientific and commercial audience, many attendees will have set priorities or deadlines aligned with clinical milestones and fiscal-year planning. Early engagement is critical for relevance.
Use Vendelux attendee insights to begin outreach in May or June, securing meetings before calendars fill. Align your messaging with attendees’ development stage and company focus so conversations at the summit are informed, efficient, and productive.
What’s Included in the mRNA-Based Therapeutics Summit 2025 Attendee List?
Vendelux provides visibility into executives expected to attend the mRNA-Based Therapeutics Summit 2025 through a combination of organizer-provided data and predictive insights. Clients can upload a list of target accounts to identify matches within the attendee list.
The enriched attendee list includes first and last name, job title, company name, company website, location (city, state, country), LinkedIn profile, verified email addresses, and phone numbers when available.
Where Is mRNA-Based Therapeutics Summit 2025?
The event will be held at The Westin Boston Seaport District in Boston, Massachusetts, United States.
When Is mRNA-Based Therapeutics Summit 2025?
mRNA-Based Therapeutics Summit 2025 is scheduled for July 21, 2025.
What Type of Event Is mRNA-Based Therapeutics Summit 2025?
This is a scientific and business-focused summit tailored to the biopharmaceutical industry, with a concentration on accelerating the development of mRNA-based therapies. The event features keynote presentations, technical sessions, and panel discussions, along with extensive networking opportunities for clinical and R&D leaders.
How Many People Attend mRNA-Based Therapeutics Summit 2025?
The summit is expected to attract over 300 attendees from across the United States, Europe, and Asia, primarily consisting of director and VP-level professionals, department heads in clinical development, C-level executives at biotechnology firms, and decision-makers from large pharmaceutical companies.
